Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04356443 · ClinicalTrials.gov registry record
Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 25
- Enrollment target
NCT04356443: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT04356443 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04356443 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This study uses the AirGo band to monitor changes in tidal ventilation in spontaneously breathing patients with COVID-19 associated respiratory failure. It aims to recognize patterns of ventilation associated with worsening respiratory failure in this patient population. If successful, this study will lead to the development of new robust methods for real-time, continuous monitoring of respiratory function in patients with respiratory failure. In turn, such monitoring methods may enable improvements in the medical management of respiratory failure and timing of interventions.
Interventions
- DEVICE AirGo Respiratory Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-04-15 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04356443
The ClinicalTrials.gov registry entry for NCT04356443 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AirGo Respiratory Monitor is the first listed.
NCT04356443 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04356443 about?
NCT04356443 is a clinical study titled "Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection". This study uses the AirGo band to monitor changes in tidal ventilation in spontaneously breathing patients with COVID-19 associated respiratory failure. It aims to recognize patterns of ventilation associated with worsening respiratory failure in this patient population. If successful, this study wi...
What is the current status of trial NCT04356443?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2020-04-15. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04356443?
The interventions under investigation include: AirGo Respiratory Monitor (DEVICE).
Who is sponsoring clinical trial NCT04356443?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.